Evidence map›Paper›PMID 34548610›Full record

ArticleCommunications biology2021

Prenylcysteine oxidase 1, an emerging player in atherosclerosis.

C Banfi, R Baetta, S S Barbieri, M Brioschi, A Guarino, S Ghilardi, L Sandrini, S Eligini, G Polvani, O Bergman and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06935578 (RAre, But Not aLone), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06935578 recruitingnot on this mapstarted 2023, after this paper: background citation

RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)

TypeobservationalSponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaRan2023 to 2026Enrolled500ConditionsCADASIL, CADASIL (Diagnosis), Moya Moya Disease, Moyamoya
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Prenylcysteine Oxidase 1 Deficiency Protects the Cardiac Muscle Cell Line HL-1 Against Ischaemic/Hypoxic Stress.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis.Antioxidants (Basel, Switzerland) · 2023
    Article
  17. Prenylcysteine Oxidase 1 (PCYOX1), a New Player in Thrombosis.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

C BanfiCentro Cardiologico Monzino IRCCS, Milano, Italy. cristina.banfi@ccfm.it.ORCID http://orcid.org/0000-0003-3346-9879
R BaettaCentro Cardiologico Monzino IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0001-7190-4638
S S BarbieriCentro Cardiologico Monzino IRCCS, Milano, Italy.
M BrioschiCentro Cardiologico Monzino IRCCS, Milano, Italy.ORCID http://orcid.org/0000-0003-4706-4418
A GuarinoCardiovascular Tissue Bank of Milan, Centro Cardiologico Monzino IRCCS, Milano, Italy.
S GhilardiCentro Cardiologico Monzino IRCCS, Milano, Italy.
L SandriniCentro Cardiologico Monzino IRCCS, Milano, Italy.
S EliginiCentro Cardiologico Monzino IRCCS, Milano, Italy.
G PolvaniCardiovascular Tissue Bank of Milan, Centro Cardiologico Monzino IRCCS, Milano, Italy.
O BergmanDepartment of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4323-8150
P ErikssonDepartment of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
E TremoliCentro Cardiologico Monzino IRCCS, Milano, Italy.
Centro Cardiologico Monzino · ITKarolinska University Hospital · SEUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research into the pathophysiology of atherosclerosis has considerably increased our understanding of the disease complexity, but still many questions remain unanswered, both mechanistically and pharmacologically. Here, we provided evidence that the pro-oxidant enzyme Prenylcysteine Oxidase 1 (PCYOX1), in the human atherosclerotic lesions, is both synthesized locally and transported within the subintimal space by proatherogenic lipoproteins accumulating in the arterial wall during atherogenesis. Further, Pcyox1 deficiency in Apoe

Indexed as

AdultAgedAnimalsAtherosclerosisCarbon-Sulfur LyasesFemaleHumansInflammationMaleMiceMiddle AgedOxidative StressPlatelet AdhesivenessCarbon-Sulfur LyasesPCYOX1 protein, humanPcyox1 protein, mouse

Identifiers

PMID34548610
PMCPMC8455616
OpenAlexW3200526218

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.